Ensign Peak Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-167,325
Closed -$17M 1719
2025
Q4
$17M Sell
167,325
-1,154,563
-87% -$92.7M 0.03% 312
2025
Q3
$72.3M Sell
1,321,888
-65,909
-5% -$3.29M 0.12% 150
2025
Q2
$73.7M Buy
1,387,797
+168,345
+14% +$8.55M 0.13% 150
2025
Q1
$52.8M Sell
1,219,452
-69,424
-5% -$3.52M 0.1% 182
2024
Q4
$72.4M Buy
1,288,876
+87,401
+7% +$5.44M 0.13% 146
2024
Q3
$81.8M Sell
1,201,475
-613,662
-34% -$34.6M 0.14% 127
2024
Q2
$76.7M Sell
1,815,137
-607
-0% -$33.4K 0.14% 129
2024
Q1
$125M Buy
1,815,744
+290,841
+19% +$18.4M 0.23% 92
2023
Q4
$113M Sell
1,524,903
-498,679
-25% -$32.7M 0.22% 96
2023
Q3
$138M Sell
2,023,582
-524,645
-21% -$44.5M 0.29% 75
2023
Q2
$239M Sell
2,548,227
-308,179
-11% -$24M 0.49% 51
2023
Q1
$194M Buy
2,856,406
+254,519
+10% +$16.4M 0.42% 57
2022
Q4
$129M Buy
2,601,887
+988,811
+61% +$40.4M 0.29% 87
2022
Q3
$52.4M Sell
1,613,076
-530,300
-25% -$21.9M 0.13% 150
2022
Q2
$84.4M Sell
2,143,376
-98,672
-4% -$5.28M 0.2% 109
2022
Q1
$157M Sell
2,242,048
-146,764
-6% -$10.7M 0.32% 73
2021
Q4
$186M Buy
2,388,812
+406,554
+21% +$35.9M 0.36% 70
2021
Q3
$189M Buy
1,982,258
+119,426
+6% +$12.6M 0.39% 67
2021
Q2
$232M Buy
1,862,832
+103,177
+6% +$12.3M 0.47% 53
2021
Q1
$232M Buy
1,759,655
+26,468
+2% +$3.62M 0.5% 49
2020
Q4
$230M Sell
1,733,187
-341,750
-16% -$41.3M 0.52% 43
2020
Q3
$212M Sell
2,074,937
-201,707
-9% -$17.4M 0.53% 41
2020
Q2
$198M Sell
2,276,644
-771,335
-25% -$61.6M 0.54% 44
2020
Q1
$177M Buy
3,047,979
+800,317
+36% +$65M 0.59% 44
2019
Q4
$208M Buy
+2,247,662
New +$198M 0.55% 46

Other funds holding EXAS

Ensign Peak Advisors's EXAS Position: Q1 2026 in Review

Ensign Peak Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 167,325 shares — an estimated $17M sold.

Ensign Peak Advisors first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $239M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ensign Peak Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ensign Peak Advisors sold 167,325 Exact Sciences shares in Q1 2026, an estimated $17M.
  • Ensign Peak Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Ensign Peak Advisors's Exact Sciences position peaked at $239M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.